Arianna Johnson, Forbes Staff

Author's posts

Covid Vaccines: Here’s Evidence They Work—Despite Persistent Misinformation—Along With Side Effects And Common Misconceptions

Studies estimate Covid vaccines prevented millions of deaths and even more hospitalizations.

Antibiotic-Resistant Gonorrhea Found In U.S.: Here’s What To Know

Gonorrhea has long shown resistance to antibiotics, with public health officials recommending only high doses of one antibiotic for treatment.

Hybrid Immunity: Why It Is Highly Effective Against Covid And Hospitalization

Those with hybrid immunity are more protected against severe Covid symptoms and hospitalization than those with only infection immunity.

Oil Pulling Has Gone Viral On TikTok—But Does It Make Your Teeth Brighter? We Asked The Experts

Oil pulling originated in Ancient India and has been practiced for thousands of years.

Weight-Loss Drugs And Surgery Now Recommended For Some Children: Here’s What’s Available And What Doctors May Prescribe

The guidelines now focus on obesity treatment rather than prevention.

Lecanemab: How The FDA-Approved Alzheimer’s Drug Works And Its Possible Side Effects

A patient died from a stroke during a clinical trial for the drug, and some researchers suspect lecanemab played a part.

Omicron Subvariant XBB.1.5: The Dominant Covid Strain In The U.S. Surges In Major Metro Areas With Slightly Different Symptoms

Although it is the dominant strain in the country, XBB.1.5 has hit the Northeast the hardest, with around 75% of cases in the region caused by XBB.1.5.

What To Know About Ozempic: The Diabetes Drug Becomes A Viral Weight Loss Hit (Elon Musk Boasts Using It) Creating A Shortage

The FDA has the drug listed on its medication shortage list, causing type two diabetics to call around to multiple pharmacies before finding one with Ozempic in stock.

This Wife And Husband Duo Raised $15 Million To Expand Access To Mental Healthcare

Chrstine Carville and Marc Goldberg have raised a series A round to expand their mental health startup Resilience Lab, which aims to boost the number and diversity of providers in the sector.

Why These Brothers Left Their $515 Million Fintech Company To Start A Healthcare Business

Nayya cofounders Aman and Akash Magoon have raised $5.6 million in capital for their new venture, Adonis, which aims to speed up the medical billing process.